Fei Liu

Research Interests: Arrhythmia, Atrial Fibrillation, Catheter Ablation, SGLT2-inhibitors, Biomarkers, Cardio-oncology

Biography: 
Fei Liu is an Chinese and currently working as a clinical doctor in cardiology department in First affiliated hospital of Dalian medical University. He started medical career with a seven years medical training program in 2011 and obtained Master of Medicine in 2018. He successfully completed Ph.D. in Cardiology (2021) at the First Affiliated Hospital of Dalian Medical University under Prof. Xia Yunlong. His scientific research attitude and development are related cardiovascular medicine particularly Arrhythmia, catheter ablation and Cardio-oncology. He published more than 9 SCI papers as first author and more than 5 SCI papers as coauthor. He has presented in several major international conferences. He believes firmly in the value of international research collaboration and is actively seeking collaborative opportunities in Atrial fibrillation, Catheter ablation and Cardio-oncology research.

Websitehttps://www.researchgate.net/profile/Fei-Liu-83

Selected publications:
Liu, F.; Hidru, T. H.; Gao, R.; Lin, Y.; Liu, Y.; Fang, F.; Liu, J.; Li, H.; Yang, X.; Xia, Y., Cancer patients with potential eligibility for vascular endothelial growth factor antagonists use have an increased risk for cardiovascular diseases comorbidities. J Hypertens 2020, 38 (3), 426-433.(IF 4.844)
Liu, F.; Xin, Z.; Bin Waleed, K.; Lin, Y.; Tse, G.; Luhanga, A.; Sun, Y.; Gao, L.; Yin, X.; Xia, Y., CHA2DS2-VASc Score as a Predictor of New-Onset Atrial Fibrillation After Catheter Ablation of Typical Atrial Flutter. Frontiers in Physiology 2020, 11 (558). (IF 4.566)
Liu, F.; Sun, W.; Li, Y.; Sun, Y.; Yu, X.; Yin, X.; Xia, Y., Low-Level Stimulation and Ethanol Ablation of the Vein of Marshall Prevent the Vagal-Mediated AF. Frontiers in Cardiovascular Medicine 2021, 8 (365). (IF 6.05)